Crane (NYSE:CR – Get Free Report) will be releasing its earnings data after the market closes on Monday, October 28th. Analysts expect Crane to post earnings of $1.29 per share for the quarter. Crane has set its FY24 guidance at $4.95-$5.15 EPS and its FY 2024 guidance at 4.950-5.150 EPS.Persons interested in listening to the company’s earnings conference call can do so using this link.
Crane (NYSE:CR – Get Free Report) last issued its quarterly earnings results on Monday, July 29th. The conglomerate reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.06. The business had revenue of $581.00 million for the quarter, compared to the consensus estimate of $568.33 million. Crane had a return on equity of 24.45% and a net margin of 13.10%. The business’s quarterly revenue was up 14.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.10 earnings per share. On average, analysts expect Crane to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.
Crane Stock Performance
Shares of CR stock opened at $149.00 on Friday. The business’s fifty day simple moving average is $154.09 and its 200-day simple moving average is $148.01. The company has a market cap of $8.52 billion, a PE ratio of 39.95, a PEG ratio of 1.93 and a beta of 0.77. The company has a current ratio of 1.18, a quick ratio of 0.88 and a debt-to-equity ratio of 0.29. Crane has a 12-month low of $90.91 and a 12-month high of $163.48.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on CR
About Crane
Crane Company, together with its subsidiaries, manufactures and sells engineered industrial products in the United States, Canada, the United Kingdom, Continental Europe, and internationally. The company operates in three segments: Aerospace & Electronics, Process Flow Technologies, and Engineered Materials.
See Also
- Five stocks we like better than Crane
- What is a Bond Market Holiday? How to Invest and Trade
- Texas Roadhouse Stock Steering for New Highs This Year
- Following Congress Stock Trades
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- How to buy stock: A step-by-step guide for beginners
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Crane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crane and related companies with MarketBeat.com's FREE daily email newsletter.